Items tagged with Treatment

International support for compulsory license to address access barriers to life-saving TB medicines (post with simple image)

Advocates urge the Indian government to issue compulsory licenses for patents on bedaquiline and delamanid to make the drugs more affordable and accessible.

TAGline: Delivering on the promise of long-acting formulations (post with simple image)

October 2021 issue of TAGline delves deep into the development of long-acting formulations for the treatment and prevention of HIV, TB, hepatitis C, and malaria.

An Activist’s Guide to Shorter Treatment for Drug-Sensitive TB (post with simple image)

This new resource provides activists with information about two shorter treatment regimens for drug-sensitive TB, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

TAG's 2021 Pipeline Report: TB chapters released (post with simple image)

Treatment Action Group (TAG) launches newly available TB chapters of its 2021 Pipeline Report.

Advocates call on Unitaid to prioritise AIDS deaths and TB treatment in its investment and strategic plans (post with simple image)

Prioritising AIDS/advanced HIV disease and TB treatment in Unitaid’s Investment Plan and Strategic Framework for 2022-2026.

Advocates call on Indian government to stop using injectable agents for the treatment of drug-resistant TB (post with simple image)

Advocates urge the Indian government to stop using kanamycin for the treatment of drug-resistant TB and instead scale up access to all oral regimens.

Key changes to the treatment of drug-resistant TB (post with simple image)

The World Health Organization issues rapid communication on updated guidance for the treatment of drug-resistant TB.

Major improvements in quality of life for people with drug-susceptible TB expected following updates in TB treatment regimens (post with simple image)

The updated WHO consolidated guidelines on treatment of drug-susceptible TB include a new recommendation for the use of a 4-month regimen composed of isoniazid, rifapentine, moxifloxacin and pyrazinamid.

Activists across the world demand urgent action to improve access to lifesaving TB medicine, bedaquiline (post with simple image)

Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.

Page 93 of 93 · Total posts: 0

←First 92 93